“Design and rational of the OPTIMA Study: Retreatment or Step-Up Therapy with Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU)” (2017) SKIN The Journal of Cutaneous Medicine, 1(3.1), p. s125. doi:10.25251/skin.1.supp.124.